Topic Highlight
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2013; 19(43): 7515-7530
Published online Nov 21, 2013. doi: 10.3748/wjg.v19.i43.7515
Table 1 Advantages and disadvantages of the bridging and downstaging procedures for hepatocellular carcinoma in cirrhotic patients who are candidates for liver transplantation
AdvantagesDisadvantages
ResectionHigher complete effectiveness than non-surgical proceduresUnfeasible in patients with decompensated liver disease or severe portal hypertension
More simple in cases with peripheral subglissonian nodules
TACEMore effective using the selective/superselective technique in well-vascularized nodules with large feeding arteriesUnfeasible in patients with severely reduced portal vein flow, intratumoral arteriovenous fistula, or renal failure (creatinine clearance < 30 mL/min)
TAREPossible better effectiveness than TACE in cases with multiple nodulesLess experience with TARE than TACEHigh cost
RFAMore effective in nodules ≤ 3 cmPotentially dangerous in patients with impaired clotting parameters or lesions located superficially or near the gallbladder, major bile ducts, or bowel loops
PEIMore effective in nodules ≤ 3 cmSuitable in patients with impaired clotting parameters or lesions located in dangerous sites for thermal ablationLess effective than RFA for nodules > 2 cm
PLAMore effective in nodules ≤ 3 cmSuitable in patients with impaired clotting parametersLess experience with PLA than RFATechnically complexPotentially dangerous in cases of lesions located superficially or near the gallbladder, major bile ducts, or bowel loops
MWAPossible better effectiveness than RFA in nodules ≥ 3 cm or located near large vesselsLess experience with MWA than RFAPotentially dangerous in patients with impaired clotting parameters or withlesions located superficially or near the gallbladder, major bile ducts, or bowel loops